Robert Harte
Impact in
-
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Advanced MRI Techniques and Applications
-
- Colorectal Cancer Surgical Treatments
Papers in
-
- Medical Imaging Techniques and Applications 5
- Radiomics and Machine Learning in Medical Imaging 2
- Oncology 4
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Surgical Treatments 1
- Drug Transport and Resistance Mechanisms 1
- Co-authors
- Pat Price (8 shared papers)Julian C. Matthews (7 shared papers)Terry Jones (7 shared papers)Frank Brady (4 shared papers)Safiye Osman (4 shared papers)David Sebag‐Montefiore (2 shared papers)Rob Glynne‐Jones (2 shared papers)Paula Wells (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)The Lancet Oncology (1 paper)Applied Radiation and Isotopes (1 paper)
- Partner nations
- United KingdomNetherlandsNew Zealand
In The Last Decade
Robert Harte
12 papers receiving 313 citations
Peers
Comparison fields: 5 of 46
- Radiology, Nuclear Medicine and Imaging 130
- Oncology 77
- Surgery 96
- Genetics 21
- Cancer Research 28
Countries citing papers authored by Robert Harte
This map shows the geographic impact of Robert Harte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Harte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Harte more than expected).
Fields of papers citing papers by Robert Harte
This network shows the impact of papers produced by Robert Harte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Harte. The network helps show where Robert Harte may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Harte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 99 | |
| 2 | 2001 | 57 | |
| 3 | 1999 | 44 | |
| 4 | 1998 | 42 | |
| 5 | 2020 | 17 | |
| 6 | Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials. | 1997 | 15 |
| 7 | New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomography. | 1993 | 14 |
| 8 | Sources of error in tissue and tumor measurements of 5-[18F]fluorouracil. | 1998 | 11 |
| 9 | 1996 | 9 | |
| 10 | 1997 | 6 | |
| 11 | 2002 | 2 | |
| 12 | 1997 | 2 |
About Robert Harte
Robert Harte is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 12 papers that have together received 318 indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (5 papers), Cancer Treatment and Pharmacology (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Colorectal Cancer Surgical Treatments (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (130 citations), Oncology (77 citations), Surgery (96 citations), Genetics (21 citations) and Cancer Research (28 citations). Robert Harte has collaborated with scholars based in United Kingdom, Netherlands and New Zealand. Frequent co-authors include Pat Price, Julian C. Matthews, Terry Jones, Frank Brady, Safiye Osman, David Sebag‐Montefiore, Rob Glynne‐Jones, Paula Wells, Latha Kadalayil and Rubina Begum. Their work appears in journals such as Journal of Clinical Oncology, Clinical Oncology, Cancer Chemotherapy and Pharmacology, The Lancet Oncology and Applied Radiation and Isotopes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.